We are live on ! Find out more
BBH icon

VanEck Biotech ETF

78 hedge funds and large institutions have $85.6M invested in VanEck Biotech ETF in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more call options, than puts

Call options by funds: $9.51M | Put options by funds: $4.32M

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

10% more funds holding

Funds holding: 7178 (+7)

6.7% less ownership

Funds ownership: 22.25%15.56% (-6.7%)

28% less capital invested

Capital invested by funds: $120M → $85.6M (-$33.9M)

39% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 33

Holders
78
Holders Change
+7
Holders Change %
+9.86%
% of All Funds
2.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
20
Reduced
33
Closed
6
Calls
$9.51M
Puts
$4.32M
Net Calls
+$5.19M
Net Calls Change
+$2.73M
Name Holding Trade Value Shares
Change
Change in
Stake
BC
76
Barnett & Company
Tennessee
$10K
MFW
77
Mosaic Family Wealth
Missouri
$2K +$107 +1 +8%
LFM
78
Lumina Fund Management
New York
-$3.7M -64,400 Closed
Ameriprise
79
Ameriprise
Minnesota
-$1.07M -10,365 Closed
HSBC Holdings
80
HSBC Holdings
United Kingdom
-$728K -7,017 Closed
AIG
81
American International Group
New York
-$242K -2,328 Closed
SHJ
82
Sharkey, Howes & Javer
Colorado
-$36K -346 Closed
WTB
83
Washington Trust Bank
Washington
-$21K -200 Closed

BBH Hedge Fund Activity: Q2 2016 in Review

78 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2016, worth a combined $85.6M — down 28% from $120M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BBH positions and 6 closed out — a net gain of 7 holders — while 20 added to existing stakes and 33 trimmed.

The largest buyer was Timber Hill, adding an estimated $1.92M. The largest seller was Morgan Stanley, cutting an estimated $13M.

  • 78 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2016, up from 71 in Q1 2016.
  • Funds reported $85.6M of VanEck Biotech ETF stock for Q2 2016, down 28% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q2 2016 and 6 closed out, a net change of +7 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2016 was Timber Hill, an estimated $1.92M added.
  • The largest VanEck Biotech ETF seller in Q2 2016 was Morgan Stanley, an estimated $13M sold.

Based on aggregated 13F filings for Q2 2016.